BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32875624)

  • 21. Direct and indirect estimates of HIV-1 incidence in a high-prevalence population.
    Cleghorn FR; Jack N; Murphy JR; Edwards J; Mahabir B; Paul R; O'Brien T; Greenberg M; Weinhold K; Bartholomew C; Brookmeyer R; Blattner WA
    Am J Epidemiol; 1998 May; 147(9):834-9. PubMed ID: 9583713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simpler tool for estimation of HIV incidence from cross-sectional, age-specific prevalence data.
    Rajan SS; Sokal D
    J Epidemiol Community Health; 2011 Feb; 65(2):111-5. PubMed ID: 20558420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening tests for active pulmonary tuberculosis in children.
    Vonasek B; Ness T; Takwoingi Y; Kay AW; van Wyk SS; Ouellette L; Marais BJ; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013693. PubMed ID: 34180536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting.
    Wester CW; Koethe JR; Shepherd BE; Stinnette SE; Rebeiro PF; Kipp AM; Hong H; Bussmann H; Gaolathe T; McGowan CC; Sterling TR; Marlink RG
    AIDS; 2011 Jul; 25(12):1471-9. PubMed ID: 21572309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial.
    Klock E; Wilson E; Fernandez RE; Piwowar-Manning E; Moore A; Kosloff B; Bwalya J; Bell-Mandla N; James A; Ayles H; Bock P; Donnell D; Fidler S; Hayes R; Eshleman SH; Laeyendecker O;
    J Int AIDS Soc; 2021 Dec; 24(12):e25830. PubMed ID: 34897992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.
    Janssen RS; Satten GA; Stramer SL; Rawal BD; O'Brien TR; Weiblen BJ; Hecht FM; Jack N; Cleghorn FR; Kahn JO; Chesney MA; Busch MP
    JAMA; 1998 Jul; 280(1):42-8. PubMed ID: 9660362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.
    Moyo S; LeCuyer T; Wang R; Gaseitsiwe S; Weng J; Musonda R; Bussmann H; Mine M; Engelbrecht S; Makhema J; Marlink R; Baum MK; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):29-36. PubMed ID: 23937344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pseudo-likelihood method for estimating misclassification probabilities in competing-risks settings when true-event data are partially observed.
    Mpofu PB; Bakoyannis G; Yiannoutsos CT; Mwangi AW; Mburu M
    Biom J; 2020 Nov; 62(7):1747-1768. PubMed ID: 32520411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of HIV incidence using multiple biomarkers.
    Brookmeyer R; Konikoff J; Laeyendecker O; Eshleman SH
    Am J Epidemiol; 2013 Feb; 177(3):264-72. PubMed ID: 23302151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing intramammary infection: Controlling misclassification bias in longitudinal udder health studies.
    Haine D; Dohoo I; Scholl D; Dufour S
    Prev Vet Med; 2018 Feb; 150():162-167. PubMed ID: 29169686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection and Misclassification Biases in Longitudinal Studies.
    Haine D; Dohoo I; Dufour S
    Front Vet Sci; 2018; 5():99. PubMed ID: 29892604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should biomarker estimates of HIV incidence be adjusted?
    Brookmeyer R
    AIDS; 2009 Feb; 23(4):485-91. PubMed ID: 19165087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of False-Negative Human Immunodeficiency Virus Rapid Tests Performed on Oral Fluid in 3 International Clinical Research Studies.
    Curlin ME; Gvetadze R; Leelawiwat W; Martin M; Rose C; Niska RW; Segolodi TM; Choopanya K; Tongtoyai J; Holtz TH; Samandari T; McNicholl JM;
    Clin Infect Dis; 2017 Jun; 64(12):1663-1669. PubMed ID: 28369309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay.
    McDougal JS; Parekh BS; Peterson ML; Branson BM; Dobbs T; Ackers M; Gurwith M
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):945-52. PubMed ID: 17067263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of prospective and cross-sectional measures of HIV type 1 incidence in a higher-risk cohort in Ho Chi Minh City, Vietnam.
    Sexton CJ; Costenbader EC; Vinh DT; Chen PL; Hoang TV; Lan NT; Feldblum P; Kim A; Giang le T
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):866-73. PubMed ID: 21936716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-sectional HIV incidence estimation in HIV prevention research.
    Brookmeyer R; Laeyendecker O; Donnell D; Eshleman SH
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S233-9. PubMed ID: 23764641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.
    Laeyendecker O; Kulich M; Donnell D; Komárek A; Omelka M; Mullis CE; Szekeres G; Piwowar-Manning E; Fiamma A; Gray RH; Lutalo T; Morrison CS; Salata RA; Chipato T; Celum C; Kahle EM; Taha TE; Kumwenda NI; Karim QA; Naranbhai V; Lingappa JR; Sweat MD; Coates T; Eshleman SH
    PLoS One; 2013; 8(11):e78818. PubMed ID: 24236054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study.
    Eshleman SH; Hughes JP; Laeyendecker O; Wang J; Brookmeyer R; Johnson-Lewis L; Mullis CE; Hackett J; Vallari AS; Justman J; Hodder S
    J Infect Dis; 2013 Jan; 207(2):223-31. PubMed ID: 23129758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marginal structural models for case-cohort study designs to estimate the association of antiretroviral therapy initiation with incident AIDS or death.
    Cole SR; Hudgens MG; Tien PC; Anastos K; Kingsley L; Chmiel JS; Jacobson LP
    Am J Epidemiol; 2012 Mar; 175(5):381-90. PubMed ID: 22302074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confidence intervals for biomarker-based human immunodeficiency virus incidence estimates and differences using prevalent data.
    Cole SR; Chu H; Brookmeyer R
    Am J Epidemiol; 2007 Jan; 165(1):94-100. PubMed ID: 17056640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.